All members have the option of attending our various HTC-centric events which include:
Date: Wednesday, October 4, 2023
Time: 1:00pm – 2:00pm ET
TITLE:
An injectable, extended half-life recombinant, glycopegylated factor VIII concentrate for Hemophilia A
OBJECTIVE:
Provide a clinical overview of Esperoct that supports prophylactic, on-demand and perioperative management indications in adults and children.
TARGET AUDIENCE:
All HTC Staff
SPEAKER:
Parin Chikani, PharmD, MBA
Medical Account Director, Novo Nordisk Inc
Parin Chikani, lives in the Chicagoland area and earned his Doctorate of Pharmacy degree from the University of Illinois at Chicago, College of Pharmacy and his MBA from Kellstadt Graduate School of Business. Before joining Novo Nordisk, Parin had been in the Pharmacy/Managed Care setting for over 15 years where he held many different roles and leadership positions within Pharmacy and Medical areas of the business. At Novo Nordisk, one of his roles and responsibilities is to ensure payors and clinicians are up-to-date on evidence based clinical and scientific information in the areas of Rare Diseases to help assist them with patient care.
